Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke

NCT02828540 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: HT047 High-dose group
DRUG: HT047 Low-dose group
DRUG: Placebo

Sponsor

Hocheol Kim